Our publications keep professionals working across the public, private, and academic sectors informed on the most important developments and issues in health security and biosecurity.
Find an article or report by keywords:
Biosecur Bioterror 2012;10(3):255-257
Recent cases of counterfeit and contaminated medications have raised concerns about the integrity of the US supply chain of pharmaceuticals. Moreover, shortages in oncology drugs have highlighted a weak domestic production capacity for essential medications. The FDA and the Pew Charitable Trusts have published analyses of the problems as they relate to the US's regulatory system and healthcare industry. These issues also represent a potential national security threat.